Transplantation: IdeS to desensitize organ allograft recipients

Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis

(2017) Miriam Manook et al.   LANCET

IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation

(2017) Stanley C. Jordan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection

(2016) Elisabeth Schwaiger et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The Bacterial Enzyme IdeS Cleaves the IgG-Type of B Cell Receptor (BCR), Abolishes BCR-Mediated Cell Signaling, and Inhibits Memory B Cell Activation

(2015) Sofia Järnum et al.   JOURNAL OF IMMUNOLOGY

A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients

(2015) Ashley A. Vo et al.   TRANSPLANTATION

Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS – A Novel Therapeutic Opportunity

(2015) Lena Winstedt et al.   PLoS One

Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study

(2014) B. J. Orandi et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Prospective Iterative Trial of Proteasome Inhibitor-Based Desensitization

(2014) E. S. Woodle et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure

(2012) Alexandre Loupy et al.   Nature Reviews Nephrology

Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients

(2011) M. D. Stegall et al.   AMERICAN JOURNAL OF TRANSPLANTATION